The BioSymetrics leadership team possesses significant expertise and professional experience in data science, medicine, and healthcare technology. Our solutions are underpinned by cross-disciplinary capabilities in machine learning, predictive analytics, big data, bioinformatics, computational biology, health IT, and advanced image processing and pattern analysis.
Gabriel Musso, PhD
Chief Scientific Officer, Gabe@BioSymetrics.com
Babak Afshin-Pour, PhD
VP Technology, Babak@BioSymetrics.com
Victoria Catterson, PhD
Principal Data Scientist, Victoria@BioSymetrics.com
William Hoiles, PhD
Data Scientist, Will@BioSymetrics.com
Dr. Hoiles possesses cross-disciplinary expertise in machine learning, computer science, statistical signal processing, and algorithms. His work and technical leadership are integral to our innovation in predictive modeling solutions and biomedical data science. Previously, Will was a Principal Researcher in Data Science at UCLA, and at the University of British Columbia where he developed nonparametric inference methods for clinical risk scoring and precision biosensors for drug discovery. Will is driven to apply all aspects of machine learning in combination with domain knowledge to improve R&D innovation, medicine, and patient care. Additionally, he has subject matter expertise in electrical and computer engineering, big data and medical data processing. Will also founded the UBC Formula Electric E-racing team, which focused on conversion of a 1984 Reynard Formula Ford, to the first-ever all-electric car to compete in North America autocross challenges.
Anatoly Likhatchev, CFA, MSc
VP Fintech, Tolik@BioSymetrics.com
VP Business Development, Wendy@BioSymetrics.com
Wendy is responsible for managing and leading corporate deals and collaborations for Augusta™, our biomedical machine learning (ML) software platform. She has extensive experience in biopharmaceutical and health technology cross-functional team leadership, and has led several early-stage R&D and licensing deals. As co-founder of an oncology biotech formed from targeted cancer compounds developed at Duke University Medical Center, she managed all aspects of corporate development, business planning, BD and marketing. Prior to BioSymetrics, she consulted on enterprise IT and HIE projects; served as a Director in Clinical and Quality Outcomes at Inovalon Inc., a data analytics firm; and was a Product Manager in sales and marketing at Amgen. Wendy earned her M.B.A. from Kellogg at Northwestern University, and B.A. from Duke University.